Who owns ZENAS BIOPHARMA INC?
- CUSIP Number: 98937laa3
Tip: Access positions for across all investors
Analyze quarterly positions in Zenas Biopharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Zenas Biopharma stock
Who bought or sold ZENAS BIOPHARMA INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Deerfield Management Company | 65M | $67M | 100% | Mar 2026 |
|
| Context Capital Management | 29M | $30M | 100% | Mar 2026 |
|
| Jpmorgan Chase & Co | 20M | $20M | 100% | Mar 2026 |
|
| Braidwell | 13M | $14M | 100% | Mar 2026 |
|
| Jane Street | 9.5M | $9.5M | 100% | Mar 2026 |
|
| Citadel Advisors | 8.0M | $8.3M | 100% | Mar 2026 |
|
| Leucadia National Corporation | 5.5M | $5.8M | 100% | Mar 2026 |
|
| Capstone Investment Advisors | 3.5M | $3.6M | 100% | Mar 2026 |
|
| Monashee Investment Management | 3.2M | $3.2M | 100% | Mar 2026 |
|
| D. E. Shaw & Co | 3.0M | $3.1M | 100% | Mar 2026 |
|
| Calamos Advisors | 2.5M | $2.6M | 100% | Mar 2026 |
|
| Graham Capital Management | 2.5M | $2.6M | 100% | Mar 2026 |
|
| Woodline Partners | 2.5M | $2.6M | 100% | Mar 2026 |
|
| Millennium Management | 1.2M | $1.2M | 100% | Mar 2026 |
|
| Aristeia Capital | 500k | $518k | 100% | Mar 2026 |
|